コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 and avoidance of preemptive transfusions of fresh frozen plasma.
2 2,058 nontrauma patients who did not receive fresh frozen plasma.
3 o did receive red blood cells in addition to fresh frozen plasma.
4 ion for patients receiving and not receiving fresh frozen plasma.
5 and nonleukoreduced red cells, platelets, or fresh-frozen plasma.
7 ts (0.1 [0.04] vs 1.9 U [4.5] p=0.0001), and fresh-frozen plasma (0.1 [0.07] vs 0.75 U [0.21] p=0.000
9 s of platelets (10.0 versus 6.6 U, P<0.012), fresh frozen plasma (4.8 versus 3.1 U, P<0.03), and cryo
10 platelets, 12.5 +/- 5.4 U vs. 8.6 +/- 6.4 U; fresh frozen plasma, 9.6 +/- 4.9 U vs. 4.9 +/- 3.6 U; an
12 ood products (red blood cells, platelets, or fresh frozen plasma) administered during transplantation
13 ulopathy unresponsive to vitamin K requiring fresh-frozen plasma after the first 24 hours postresecti
14 ents who received a total of 46,101 units of fresh frozen plasma and 6,251 units of apheresis platele
16 ransfusion of high plasma volume components, fresh frozen plasma and apheresis platelets, from potent
17 analysis to evaluate the association between fresh frozen plasma and infectious complication, control
18 gnificant dose-response relationship between fresh frozen plasma and infectious complications (p = .0
20 ine concentrations, the amount of platelets, fresh frozen plasma and packed erythrocytes used, and th
22 or the continued unbridled administration of fresh frozen plasma and platelets without objective evid
23 ave shown to reduce bleeding, transfusion of fresh frozen plasma and platelets, and possibly mortalit
25 association was found between transfusion of fresh frozen plasma and ventilator-associated pneumonia
26 both platelets and coagulant products (e.g., fresh-frozen plasma and recombinant-activated factor VII
27 core analysis adjusting by use of platelets, fresh frozen plasma, and cryoprecipitate; and adjusting
28 h a 68%, 56%, and 58% reduction in platelet, fresh frozen plasma, and packed erythrocyte usage, respe
29 used patients, pooled platelet concentrates, fresh frozen plasma, and packed red cells collected usin
30 ng administration of packed red blood cells, fresh frozen plasma, and platelets in ratios approximati
31 from 7.8% to 92.8% for RBCs, 0% to 97.5% for fresh-frozen plasma, and 0.4% to 90.4% for platelets.
36 use of a combination of packed red cells and fresh-frozen plasma during surgery for congenital heart
37 anticoagulation, and/or plasmapheresis with fresh-frozen plasma exchange, resolved TMA in most patie
38 ns for use of other blood components such as fresh frozen plasma (FFP) and platelet transfusions are
39 sought to define the overall utilization of fresh frozen plasma (FFP) and platelets and the impact o
40 tments utilized in clinical practice include fresh frozen plasma (FFP) and prothrombin complex concen
44 from Iraq supporting early aggressive use of fresh frozen plasma (FFP) in a 1:1 ratio to packed red b
45 plasma volume was removed and replaced with fresh frozen plasma (FFP) or with 50% FFP and 50% albumi
47 The practice of a high transfusion ratio of fresh frozen plasma (FFP) to red blood cells (RBCs) has
49 amounts of packed red blood cells (RBCs) and fresh frozen plasma (FFP) were recorded during hospital
51 8 U blood products (red blood cells [RBCs] + fresh frozen plasma [FFP] + platelets) had a median (int
52 otal of 380 non-trauma patients who received fresh frozen plasma from 2004 to 2005 were compared with
53 ciation between infection and transfusion of fresh frozen plasma in patients who did not receive conc
54 e vWf-cleaving metalloprotease is present in fresh-frozen plasma, in cryoprecipitate-depleted plasma
58 o >1.5) or clinical (transfusion >2 units of fresh frozen plasma or >1 pack of platelets in 6 hours)
61 ion of packed red blood cells (p = .442) and fresh frozen plasma (p = .063) were not different betwee
63 ive bleeding disorder treated by infusion of fresh-frozen plasma, plasma-derived FVII concentrates an
65 The administration of coagulation factors (fresh frozen plasma, prothrombin complex concentrates or
68 use of a combination of packed red cells and fresh-frozen plasma (reconstituted blood) for priming of
70 ction without prior PVE demonstrated a lower fresh frozen plasma requirement (P = 0.01), a lower peak
72 95% confidence interval [CI], 0.57 to 0.99), fresh frozen plasma (RR, 0.37; 95% CI, 0.21 to 0.64), an
75 ence of reactions to platelets compared with fresh frozen plasma suggests that a platelet-related fac
78 with an odds ratio of infection per unit of fresh frozen plasma transfused equal to 1.039 (1.013-1.0
79 -test allowed comparison of average units of fresh frozen plasma transfused to patients with and with
80 rative packed red cells (r=0.28, P=.049) and fresh frozen plasma transfusions (r=0.42, P=.004), highe
81 nternational normalized ratios, 33% received fresh-frozen plasma transfusions during their intensive
84 of platelet units (4.3 vs. 1.7, p =.05) and fresh frozen plasma units (1.1 vs. 0.6, p =.08) also was
85 tests) and the transfusion (blood units and fresh frozen plasma units) during the operative period w
86 id infusion volume (6.1-3.2 L) and increased fresh frozen plasma use (3.2-10.1 U) (both P < .05) in t
87 apy and treatment with lactulose, vitamin K, fresh frozen plasma, ventilatory assistance, and intensi
88 unoglobulin (4 cases), interferon (3 cases), fresh frozen plasma with WNV IgG (2 cases), and ribaviri
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。